REFILE-UPDATE 2-Delaware judge says Fresenius can walk away from $4.8 bln Akorn deal

Germany's Fresenius SE won a rare court ruling allowing the healthcare group to walk away from its $4.75 billion takeover of Akorn Inc , sparking a more than 50 percent fall in the U.S. generic drugmaker's shares.